Perrone, Salvatore https://orcid.org/0000-0001-8196-0481
Tomasello, Riccardo https://orcid.org/0000-0002-0870-6097
Raso, Simona https://orcid.org/0000-0002-0967-2191
Annibali, Ombretta https://orcid.org/0000-0002-3095-5313
Tafuri, Mariantonietta
Mattana, Marta https://orcid.org/0000-0001-6913-8268
Soriano, Tania https://orcid.org/0009-0005-4772-3892
Fanciullo, David
Assanto, Giovanni Manfredi https://orcid.org/0000-0002-6190-9635
Pedone, Giacinto Luca https://orcid.org/0009-0000-7727-2766
Baldacci, Erminia
Santacroce, Eugenio https://orcid.org/0009-0000-2898-5241
Markovic, Uros https://orcid.org/0000-0003-0868-5676
Giuffrida, Gaetano https://orcid.org/0000-0003-4947-3338
Ingrascì, Manuela Giuseppa https://orcid.org/0009-0001-3993-2097
Biglietto, Mario https://orcid.org/0000-0003-1487-5812
Cammarata, Claudia https://orcid.org/0000-0002-0195-9964
Totaro, Matteo
Ligia, Silvio https://orcid.org/0000-0002-2803-3766
Fattizzo, Bruno https://orcid.org/0000-0003-0857-8379
Santoro, Cristina https://orcid.org/0000-0002-7181-447X
Siragusa, Sergio https://orcid.org/0000-0002-1641-6508
Napolitano, Mariasanta https://orcid.org/0000-0001-8934-2936
Funding for this research was provided by:
Università degli Studi di Palermo
Article History
Received: 30 January 2026
Accepted: 29 April 2026
First Online: 9 May 2026
Declarations
:
: GMA Advisory board Takeda, Jazz, Research Funding Gilead, Travel Grant Lilly, Beigene. M.N. acted as consultant for Bayer, CSL Behring, Novonordisk and received speaker fees from Bayer, Sanofi, Takeda, Sobi, Novonordisk, CSL Behring, Amgen, Novartis, Grifols, Kedrion. All other authors declare no conflicts of interest.